CHARLES TOWN, W.Va., Nov. 23 ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum, today announced it has successfully concluded analysis of the recent volatility of their stock price and presented it to the Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

It appears that several institutional and corporate investors possibly got nervous over the sub-prime housing crisis and liquidated large portions of their portfolios. "Unfortunately, our equity was included in their programmed liquidation process. As a result, many individual investors followed suit, increasing the supply of stock available to purchase and driving down the price per share," according to David Phillips, Ph.D. CEO.

Meanwhile the company continued its steady growth as evidenced by the quarterly reports published on pinksheets.com. There was no bad news whatsoever relative to the actual operations of the company. "We are in better financial shape, in better marketing shape, in better R&D shape, and in better PR shape than ever before in our company's history," says Dr. Phillips.

"We have successfully renegotiated certain aspects of our original merger terms to reduce the possibility of any remaining large corporate holders of our equities from taking profits and dumping large blocks of our stock on the market. In addition, many of these original holders of large blocks of our equities have now liquidated the majority of their shares to individual investors. We expect that these new individuals may have the best long-term interests of our company in mind. This could have the desired effect of stabilizing the stock price and thus reflect the real value of our equities," states Dr. Phillips. He concluded his statement by saying, "Because I, personally, am an insider, I cannot buy my own company's stock. However, if I could, I would sell my dog if I had to, to buy some."

Beginning on Monday, November 26, 2007, RBRM will be releasing a series of twelve news releases that will describe several new initiatives that are very exciting and will help investors have a better understanding of the company's current success and plans to expand that success in the near future.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.